Author:
Pijnappel E. N.,Suurmeijer J. A.,Groot Koerkamp B.,Siveke J. T.,Salvia R.,Ghaneh P.,Besselink Marc G.,Wilmink J. W.,van Laarhoven H. W. M.
Publisher
Springer International Publishing
Reference52 articles.
1. Ter Veer E, van Kleef JJ, Schokker S, van der Woude SO, Laarman M, Haj Mohammad N, et al. Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: a systematic review and meta-analysis. Eur J Cancer. 2018;103:214–26.
2. Bradley A, Van der Meer R, McKay CJ. A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma. PLoS One. 2019;14(9):e0222270.
3. Henselmans I, van Laarhoven HWM, de Haes H, Tokat M, Engelhardt EG, van Maarschalkerweerd PEA, et al. Training for medical oncologists on shared decision-making about palliative chemotherapy: a randomized controlled trial. Oncologist. 2019;24(2):259–65.
4. Clark GM. Prognostic factors versus predictive factors: examples from a clinical trial of erlotinib. Mol Oncol. 2008;1(4):406–12.
5. Clark GM, Zborowski DM, Culbertson JL, Whitehead M, Savoie M, Seymour L, et al. Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib. J Thorac Oncol. 2006;1(8):837–46.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献